News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

Researchers Find Link to Severe Staph Infections

December 29, 2008
Article

Researchers at the University of Texas School of Public Health recently described studies that support the link between the severity of community-acquired antibiotic-resistant Staphylococcus aureus (CA-MRSA) infections and the Panton Valentine leukocidin (PVL).

The Panton Valentine leukocidin is made up of two components -- LukF-PV and LukS-PV - and is typically produced by community-acquired methicillin-resistant S. aureus (CA-MRSA). In the United States this strain is the most common CA MRSA isolate and can cause severe skin infections, pneumonia, bloodstream infections and surgical wound infections.

This work has identified using animal models that the PVL leukotoxin can be used as a vaccine against infections caused by CA-MRSA. Results from the research will be published in the December issue of Clinical Microbiology and Infection.

According to the Centers for Disease Control and Prevention (CDC), the antibiotic-resistant USA300 CA-MRSA strain is typically acquired by persons through contact with the bacteria. This Staph strain is not typically associated with hospitalizations or medical procedures.

Eric Brown, PhD, assistant professor of infectious diseases at the UT School of Public Health and colleagues also tested the virulence of PVL in CA-MRSA by using clinical strains of USA300 that did and did not contain the spore-forming toxin.

"The bacteria is not the same as it was several years ago. It has all of the weapons and toxins that other strains don't have, which makes it easier for this strain to survive efficiently inside of cells," Brown said.

"Immunity directed against LukS was more efficient in protecting mice against a USA300 infection compared to mice vaccinated with LukF-PV or alpha toxin," Brown said. His research found that LukS-PV was effective at protecting against certain types of infections reinforcing the importance of this virulence factor in the disease process. LukS-PV given through the nose protected the mice against pneumonia, conversely if administered subcutaneously it protected against skin infections.

Brown said, "The [vaccination] route and infection routes correlated with each other i.e., intranasally-immunized mice were better protected against pneumonia than subcutaneously vaccinated mice and subcutaneously-vaccinated mice were better protected against a skin infection than against pneumonia. This in part may be related to the type of immune response generated at the skin compared to the lung."

In addition, Brown and colleagues have examined the anti-PVL antibody responses in pediatric patients diagnosed with Staph infections compared to antibody responses to other USA300 virulence factors. The study found patients who had Staph infections caused by PVL-positive strains had a dominant response to the LukS and LukF proteins.

The research was supported by the UT School of Public Health, the Texas A&M Health Science Center, the Hamill Foundation, Baylor College of Medicine and the Université de Lyon, France.

The article is titled "The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300."

 

 

 

 

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content

Stretcher and HAIs  (Image courtesy of author through AI)

How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels

Donald Sipp, MBA, RESE, CHESP, CHTI-2, CMIP, PMP
July 3rd 2025
Article

Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.


Hot Topics With Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC

Hot Topics for IPC on July 2, 2025

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
July 2nd 2025
Article

This Hot Topics for IPC covers the latest on ASPR, AMR, vaccines, and a study on AMR and livestock manure from Michigan State University.


The Clean Bite

Personal Protective Equipment (PPE) for Dental Professionals: A Layered Defense

Sherrie Busby, EDDA, CDSO, CDIPC
July 1st 2025
Article

Dental infection control expert Sherrie Busby tackles PPE missteps, from chin-bra masks to cropped lab coats, reminding dental teams that proper protection is crucial, not optional.


Rebecca Battjes, MPH, CIC, FAPIC; Vidya Nankoosingh, MLT, CIC; and Peter Teska, MBA

Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25

Tori Whitacre Martonicz
June 30th 2025
Article

Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.


ACIP decides on vaccinations   (Adobe Stock 606491608 by N Lawrenson/peopleimages.com)

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

Richard Payerchin
June 27th 2025
Article

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.


US Department of Health and Human Services

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

Richard Payerchin
June 26th 2025
Article

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.

Related Content

Stretcher and HAIs  (Image courtesy of author through AI)

How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels

Donald Sipp, MBA, RESE, CHESP, CHTI-2, CMIP, PMP
July 3rd 2025
Article

Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.


Hot Topics With Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC

Hot Topics for IPC on July 2, 2025

Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
July 2nd 2025
Article

This Hot Topics for IPC covers the latest on ASPR, AMR, vaccines, and a study on AMR and livestock manure from Michigan State University.


The Clean Bite

Personal Protective Equipment (PPE) for Dental Professionals: A Layered Defense

Sherrie Busby, EDDA, CDSO, CDIPC
July 1st 2025
Article

Dental infection control expert Sherrie Busby tackles PPE missteps, from chin-bra masks to cropped lab coats, reminding dental teams that proper protection is crucial, not optional.


Rebecca Battjes, MPH, CIC, FAPIC; Vidya Nankoosingh, MLT, CIC; and Peter Teska, MBA

Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25

Tori Whitacre Martonicz
June 30th 2025
Article

Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.


ACIP decides on vaccinations   (Adobe Stock 606491608 by N Lawrenson/peopleimages.com)

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

Richard Payerchin
June 27th 2025
Article

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.


US Department of Health and Human Services

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

Richard Payerchin
June 26th 2025
Article

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News